PuSH - Publication Server of Helmholtz Zentrum München

90 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
41.
Mueller, K.M.* et al.: Adipocyte glucocorticoid receptor deficiency attenuates aging and HFDinduced obesity, and impairs the feedingfasting transition. Diabetes 66, 272-286:db160381 (2016)
42.
Müller, T.D. ; Tschöp, M.H. & O'Rahilly, S.*: Metabolic precision medicines: Curing POMC deficiency. Cell Metab. 24, 194-195 (2016)
43.
Sánchez-Garrido, M.A. et al.: Fibroblast activation protein (FAP) as a novel metabolic target. Mol. Metab. 5, 1015-24 (2016)
44.
Tschöp, M.H. et al.: Unimolecular polypharmacy for treatment of diabetes and obesity. Cell Metab. 24, 51-62 (2016)
45.
Clemmensen, C. et al.: Dual melanocortin-4 receptor and GLP-1 receptor agonism amplifies metabolic benefits in diet-induced obese mice. EMBO Mol. Med. 7, 288-298 (2015)
46.
Finan, B. et al.: A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents. J. Nat. Med. 21, 27-36 (2015)
47.
Finan, B. ; Clemmensen, C. & Müller, T.D.: Emerging opportunities for the treatment of metabolic diseases: Glucagon-like peptide-1 based multi-agonists. Mol. Cell. Endocrinol. 418, 42-54 (2015)
48.
Fischer, K. et al.: The pentapeptide RM-131 promotes food intake and adiposity in wildtype mice but not in mice lacking the ghrelin receptor. Front. Nutr. 1:31 (2015)
49.
Müller, T.D. ; Clemmensen, C. ; Finan, B. ; DiMarchi, R.D.* & Tschöp, M.H.: Novel combinatorial therapies involving leptin: Opportunities for mechanistic advances and therapeutic translation in human diseases, In: Dagogo-Jack, S.* [Eds.]: Leptin : Regulation and Clinical Applications. 2015. 267-279
50.
Müller, T.D. et al.: Ghrelin. Mol. Metab. 4, 437–460 (2015)
51.
Pfluger, P.T. et al.: Calcineurin links mitochondrial elongation with energy metabolism. Cell Metab. 22, 838-850 (2015)
52.
Stemmer, K. et al.: Thermoneutral housing is a critical factor for immune function and diet-induced obesity in C57BL/6 nude mice. Int. J. Obes. 39, 791-797 (2015)
53.
Stemmer, K. et al.: FGF21 is not required for glucose homeostasis, ketosis or tumour suppression associated with ketogenic diets in mice. Diabetologia 58, 2414-2423 (2015)
54.
Wiedemann, T. ; Bielohuby, M.* ; Müller, T.D. ; Bidlingmaier, M.* & Pellegata, N.S.: Obesity in MENX rats is accompanied by high circulating levels of ghrelin and improved insulin sensitivity. Diabetes 65, 406-420 (2015)
55.
Al-Massadi, O.* et al.: Review of novel aspects of the regulation of ghrelin secretion. Curr. Drug Metab. 15, 398-413 (2014)
56.
Clemmensen, C. et al.: GLP-1/glucagon co-agonism restores leptin responsiveness in obese mice chronically maintained on an obesogenic diet. Diabetes 63, 1422-1427 (2014)
57.
Fischer, K. & Müller, T.D.: Relationship status update for PTP1B and LepR: It׳s complicated. Mol. Metab. 3, 217-218 (2014)
58.
Habegger, K.M.* et al.: Duodenal nutrient exclusion improves metabolic syndrome and stimulates villus hyperplasia. Gut 63, 1238-1246 (2014)
59.
Habegger, K.M.* et al.: GLP-1R responsiveness predicts individual gastric bypass efficacy on glucose tolerance in rats. Diabetes 63, 505-513 (2014)
60.
Hernandez, E.D.* et al.: A macrophage NBR1-MEKK3 complex triggers JNK-mediated adipose tissue inflammation in obesity. Cell Metab. 20, 499-511 (2014)